Daniel M. Freed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Daniel M. Freed has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Mark A. Lemmon
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA
5 shared publications - David S. Cafiso
Department of Chemistry and Center for Membrane Biology, University of Virginia, Charlottesville, United States
4 shared publications - Anatoly Kiyatkin
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA
2 shared publications - Josh Sommer
Chordoma Foundation 11 Durham, NC
2 shared publications Peter S. Horanyi
Department of Chemistry and ‡Department of Molecular Physiology and Biological Physics and Center for Membrane Biology, University of Virginia, Charlottesville, Virginia 22904-4319, United States
2 shared publications- Ali K. Khan
Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA 22908, USA
1 shared publication
Latest Publications
- 18 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
Systematic Characterization of Clinically Actionable Antibody-Drug Targets Across Solid Tumors to Advance Precision Oncology
The rapid expansion of antibody therapeutics is shifting the clinical bottleneck from drug availability to precise patient selection. We systematically characterize 87 clinically actionable tumor-associated antigens across solid tumors by integrating transcriptomic, proteomic, spatial, and single-cell profiles from more than 32,000 specimens to define expression prevalence, intratumoral heterogeneity, immune contexture, internalization and payload-sensitivity pathways, and translational relevance. We establish ANCHOR, a coordinate reference framework for standardizing patient RNA-seq data, and develop ReSort, a two-tiered scoring system for scalable target prioritization. ReSort enables virtual basket and umbrella trial matching, demonstrates concordance with clinical assays, predicts therapeutic response in patient-derived models, and identifies repurposing opportunities in rare malignancies. We develop an AI-based decision-support agent for antibody trial matching and construct a multimodal feature space integrating tumor- and protein-intrinsic attributes to guide systematic target discovery and prioritization. This work provides a scalable, clinically actionable approach for precision antibody-based therapies and next-generation target development.
- 18 November 2026
- Published by American Association for Cancer Research (AACR) in Cancer Discovery
Systematic Characterization of Clinically Actionable Antibody-Drug Targets Across Solid Tumors to Advance Precision Oncology
The rapid expansion of antibody therapeutics is shifting the clinical bottleneck from drug availability to precise patient selection. We systematically characterize 87 clinically actionable tumor-associated antigens across solid tumors by integrating transcriptomic, proteomic, spatial, and single-cell profiles from more than 32,000 specimens to define expression prevalence, intratumoral heterogeneity, immune contexture, internalization and payload-sensitivity pathways, and translational relevance. We establish ANCHOR, a coordinate reference framework for standardizing patient RNA-seq data, and develop ReSort, a two-tiered scoring system for scalable target prioritization. ReSort enables virtual basket and umbrella trial matching, demonstrates concordance with clinical assays, predicts therapeutic response in patient-derived models, and identifies repurposing opportunities in rare malignancies. We develop an AI-based decision-support agent for antibody trial matching and construct a multimodal feature space integrating tumor- and protein-intrinsic attributes to guide systematic target discovery and prioritization. This work provides a scalable, clinically actionable approach for precision antibody-based therapies and next-generation target development.
- 10 June 2026
- Published by Elsevier in European Journal of Cancer
- Vol. 244, 116875
A pooled analysis of phase 2 clinical trials in advanced chordoma
- 10 June 2026
- Published by Elsevier in European Journal of Cancer
- Vol. 244, 116875
A pooled analysis of phase 2 clinical trials in advanced chordoma
- Open Access
- 1 April 2016
- Published by Elsevier in Cancer Cell
- Vol. 29 (4) , 423-425
Deletion Mutations Keep Kinase Inhibitors in the Loop
- 1 April 2016
- Published by Elsevier in Cancer Cell
- Vol. 29 (4) , 423-425
Open AccessDeletion Mutations Keep Kinase Inhibitors in the Loop
- Open Access
- 10 June 2015
- Published by Springer Nature in Nature Communications
- Vol. 6 (1) , 7380
Ligand regulation of a constitutively dimeric EGF receptor
Ligand-induced receptor dimerization has traditionally been viewed as the key event in transmembrane signalling by epidermal growth factor receptors (EGFRs). Here we show that the Caenorhabditis elegans EGFR orthologue LET-23 is constitutively dimeric, yet responds to its ligand LIN-3 without changing oligomerization state. SAXS and mutational analyses further reveal that the preformed dimer of the LET-23 extracellular region is mediated by its domain II dimerization arm and resembles other EGFR extracellular dimers seen in structural studies. Binding of LIN-3 induces only minor structural rearrangements in the LET-23 dimer to promote signalling. Our results therefore argue that EGFR can be regulated by allosteric changes within an existing receptor dimer—resembling signalling by insulin receptor family members, which share similar extracellular domain compositions but form covalent dimers.
- 10 June 2015
- Published by Springer Nature in Nature Communications
- Vol. 6 (1) , 7380
Open AccessLigand regulation of a constitutively dimeric EGF receptor
Ligand-induced receptor dimerization has traditionally been viewed as the key event in transmembrane signalling by epidermal growth factor receptors (EGFRs). Here we show that the Caenorhabditis elegans EGFR orthologue LET-23 is constitutively dimeric, yet responds to its ligand LIN-3 without changing oligomerization state. SAXS and mutational analyses further reveal that the preformed dimer of the LET-23 extracellular region is mediated by its domain II dimerization arm and resembles other EGFR extracellular dimers seen in structural studies. Binding of LIN-3 induces only minor structural rearrangements in the LET-23 dimer to promote signalling. Our results therefore argue that EGFR can be regulated by allosteric changes within an existing receptor dimer—resembling signalling by insulin receptor family members, which share similar extracellular domain compositions but form covalent dimers.
- 1 December 2014
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 29, 95-101
Putting together structures of epidermal growth factor receptors
- 1 December 2014
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 29, 95-101
Putting together structures of epidermal growth factor receptors
- 21 March 2013
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 52 (15) , 2638-2648
Monomeric TonB and the Ton Box Are Required for the Formation of a High-Affinity Transporter–TonB Complex
The energy-dependent uptake of trace nutrients by Gram-negative bacteria involves the coupling of an outer membrane transport protein to the transperiplasmic protein TonB. In this study, a soluble construct of Escherichia coli TonB (residues 33–239) was used to determine the affinity of TonB for outer membrane transporters BtuB, FecA, and FhuA. Using fluorescence anisotropy, TonB(33–239) was found to bind with high affinity (tens of nanomolar) to both BtuB and FhuA; however, no high-affinity binding to FecA was observed. In BtuB, the high-affinity binding of TonB(33–239) was eliminated by mutations in the Ton box, which yield transport-defective protein, or by the addition of a Colicin E3 fragment, which stabilizes the Ton box in a folded state. These results indicate that transport requires a high-affinity transporter–TonB interaction that is mediated by the Ton box. Characterization of TonB(33–239) using double electron–electron resonance (DEER) demonstrates that a significant population of TonB(33–239) exists as a dimer; moreover, interspin distances are in approximate agreement with interlocked dimers observed previously by crystallography for shorter TonB fragments. When the TonB(33–239) dimer is bound to the outer membrane transporter, DEER shows that the TonB(33–239) dimer is converted to a monomeric form, suggesting that a dimer–monomer conversion takes place at the outer membrane during the TonB-dependent transport cycle.
- 21 March 2013
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 52 (15) , 2638-2648
Monomeric TonB and the Ton Box Are Required for the Formation of a High-Affinity Transporter–TonB Complex
The energy-dependent uptake of trace nutrients by Gram-negative bacteria involves the coupling of an outer membrane transport protein to the transperiplasmic protein TonB. In this study, a soluble construct of Escherichia coli TonB (residues 33–239) was used to determine the affinity of TonB for outer membrane transporters BtuB, FecA, and FhuA. Using fluorescence anisotropy, TonB(33–239) was found to bind with high affinity (tens of nanomolar) to both BtuB and FhuA; however, no high-affinity binding to FecA was observed. In BtuB, the high-affinity binding of TonB(33–239) was eliminated by mutations in the Ton box, which yield transport-defective protein, or by the addition of a Colicin E3 fragment, which stabilizes the Ton box in a folded state. These results indicate that transport requires a high-affinity transporter–TonB interaction that is mediated by the Ton box. Characterization of TonB(33–239) using double electron–electron resonance (DEER) demonstrates that a significant population of TonB(33–239) exists as a dimer; moreover, interspin distances are in approximate agreement with interlocked dimers observed previously by crystallography for shorter TonB fragments. When the TonB(33–239) dimer is bound to the outer membrane transporter, DEER shows that the TonB(33–239) dimer is converted to a monomeric form, suggesting that a dimer–monomer conversion takes place at the outer membrane during the TonB-dependent transport cycle.
- 28 October 2011
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 115 (49) , 14822-14830
Lipid and Membrane Mimetic Environments Modulate Spin Label Side Chain Configuration in the Outer Membrane Protein A
In the present work, the factors that determine EPR line shapes from spin labels at the protein–hydrocarbon interface of a β-barrel membrane protein are examined. The EPR spectra from hydrocarbon facing sites in the outer membrane protein A (OmpA) are highly dependent upon the detergent or lipid into which OmpA is reconstituted. In general, line shapes at these sites are correlated with the solvent accessibility in the supporting amphiphile. A notable exception is CHAPS, which yields rigid limit EPR line shapes for labels at every position along a transmembrane β-strand in OmpA. EPR line shapes from the surface of OmpA are not strongly influenced by steric interference with neighboring side chains, but are modulated by solutes that should interact with hydrophobic surfaces. These results suggest that differences in EPR spectra in different supporting environments are not the result of differences in protein dynamics but are a result of different configurations or rotameric states that are assumed by the label. This conclusion is supported by distance measurements across the OmpA β-barrel, which indicate that labels yielding more motionally restricted line shapes interact more closely with the protein surface. These results have implications for the use of spin-label-derived distance constraints in protein structure determination and demonstrate that spin labels on membrane proteins provide a highly sensitive probe for the environment surrounding a membrane protein.
- 28 October 2011
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 115 (49) , 14822-14830
Lipid and Membrane Mimetic Environments Modulate Spin Label Side Chain Configuration in the Outer Membrane Protein A
In the present work, the factors that determine EPR line shapes from spin labels at the protein–hydrocarbon interface of a β-barrel membrane protein are examined. The EPR spectra from hydrocarbon facing sites in the outer membrane protein A (OmpA) are highly dependent upon the detergent or lipid into which OmpA is reconstituted. In general, line shapes at these sites are correlated with the solvent accessibility in the supporting amphiphile. A notable exception is CHAPS, which yields rigid limit EPR line shapes for labels at every position along a transmembrane β-strand in OmpA. EPR line shapes from the surface of OmpA are not strongly influenced by steric interference with neighboring side chains, but are modulated by solutes that should interact with hydrophobic surfaces. These results suggest that differences in EPR spectra in different supporting environments are not the result of differences in protein dynamics but are a result of different configurations or rotameric states that are assumed by the label. This conclusion is supported by distance measurements across the OmpA β-barrel, which indicate that labels yielding more motionally restricted line shapes interact more closely with the protein surface. These results have implications for the use of spin-label-derived distance constraints in protein structure determination and demonstrate that spin labels on membrane proteins provide a highly sensitive probe for the environment surrounding a membrane protein.
- 6 September 2011
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 50 (41) , 8792-8803
Molecular Origin of Electron Paramagnetic Resonance Line Shapes on β-Barrel Membrane Proteins: The Local Solvation Environment Modulates Spin-Label Configuration
In this work, electron paramagnetic resonance (EPR) spectroscopy and X-ray crystallography were used to examine the origins of EPR line shapes from spin-labels at the protein–lipid interface on the β-barrel membrane protein BtuB. Two atomic-resolution structures were obtained for the methanethiosulfonate spin-label derivatized to cysteines on the membrane-facing surface of BtuB. At one of these sites, position 156, the label side chain resides in a pocket formed by neighboring residues; however, it extends from the protein surface and yields a single-component EPR spectrum in the crystal that results primarily from fast rotation about the fourth and fifth bonds linking the spin-label to the protein backbone. In lipid bilayers, site 156 yields a multicomponent spectrum resulting from different rotameric states of the labeled side chain. Moreover, changes in the lipid environment, such as variations in bilayer thickness, modulate the EPR spectrum by modulating label rotamer populations. At a second site, position 371, the labeled side chain interacts with a pocket on the protein surface, leading to a highly immobilized single-component EPR spectrum that is not sensitive to hydrocarbon thickness. This spectrum is similar to that seen at other sites that are deep in the hydrocarbon, such as position 170. This work indicates that the rotameric states of spin-labels on exposed hydrocarbon sites are sensitive to the environment at the protein–hydrocarbon interface, and that this environment may modulate weak interactions between the labeled side chain and the protein surface. In the case of BtuB, lipid acyl chain packing is not symmetric around the β-barrel, and EPR spectra from labeled hydrocarbon-facing sites in BtuB may reflect this asymmetry. In addition to facilitating the interpretation of EPR spectra of membrane proteins, these results have important implications for the use of long-range distance restraints in protein structure refinement that are obtained from spin-labels.
- 6 September 2011
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 50 (41) , 8792-8803
Molecular Origin of Electron Paramagnetic Resonance Line Shapes on β-Barrel Membrane Proteins: The Local Solvation Environment Modulates Spin-Label Configuration
In this work, electron paramagnetic resonance (EPR) spectroscopy and X-ray crystallography were used to examine the origins of EPR line shapes from spin-labels at the protein–lipid interface on the β-barrel membrane protein BtuB. Two atomic-resolution structures were obtained for the methanethiosulfonate spin-label derivatized to cysteines on the membrane-facing surface of BtuB. At one of these sites, position 156, the label side chain resides in a pocket formed by neighboring residues; however, it extends from the protein surface and yields a single-component EPR spectrum in the crystal that results primarily from fast rotation about the fourth and fifth bonds linking the spin-label to the protein backbone. In lipid bilayers, site 156 yields a multicomponent spectrum resulting from different rotameric states of the labeled side chain. Moreover, changes in the lipid environment, such as variations in bilayer thickness, modulate the EPR spectrum by modulating label rotamer populations. At a second site, position 371, the labeled side chain interacts with a pocket on the protein surface, leading to a highly immobilized single-component EPR spectrum that is not sensitive to hydrocarbon thickness. This spectrum is similar to that seen at other sites that are deep in the hydrocarbon, such as position 170. This work indicates that the rotameric states of spin-labels on exposed hydrocarbon sites are sensitive to the environment at the protein–hydrocarbon interface, and that this environment may modulate weak interactions between the labeled side chain and the protein surface. In the case of BtuB, lipid acyl chain packing is not symmetric around the β-barrel, and EPR spectra from labeled hydrocarbon-facing sites in BtuB may reflect this asymmetry. In addition to facilitating the interpretation of EPR spectra of membrane proteins, these results have important implications for the use of long-range distance restraints in protein structure refinement that are obtained from spin-labels.